Allen Institute for Artificial Intelligence
supp.ai logo
supp.ai

Discover Supplement-Drug Interactions

Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: 3 years ago

Possible Interaction: Glucose and Orlistat

supplement:

Glucose

Research Papers that Mention the Interaction

When compared with the placebo, the orlistat administration resulted in a significantly enhanced postprandial increase in GLP-1 and C-peptide levels and attenuated the postprandial rise in glucose and triglycerides.
Diabetes care  •  2004  |  View Paper
Gastric emptying of both oil (P < 0.001) and glucose (P < 0.0005) was faster after orlistat compared with control.
The Journal of clinical endocrinology and metabolism  •  2003  |  View Paper
orlistat lost more weight (mean +/- SEM 9.9 +/- 0.4 vs 6.1 +/- 0.5 kg, p = 0.… greater decreases in plasma cholesterol (p = 0.0001), LDL cholesterol (p = 0.0001), triglycerides (p = 0.06), glucose (p = 0.07), and insulin (p = 0.… with the diet-only treated patients.
The American journal of cardiology  •  2003  |  View Paper
Fasting glucose (0.82 and 0.17 mmol/l, P = 0.01) and total cholesterol (0.85 and 0.56 mmol/l, P = 0.05) were reduced to a greater extent with orlistat than with diet alone.
Journal of hypertension  •  2003  |  View Paper
Total cholesterol (-21.3 +/- 24.7 mg/dL; p < 0.001), low-density lipoprotein-cholesterol (-17.3 +/- … mg/dL; p < 0.0001), fasting insulin (-13.7 +/- 19.0 microU/mL; p < 0.02), and fasting glucose (-15.4 +/- 7.4 mg/dL; ….003) were also significantly lower after orlistat.
Obesity research  •  2002  |  View Paper
Total cholesterol, low-density lipoprotein (LDL) cholesterol, LDL/high-density lipoprotein ratio, and concentrations of glucose and insulin decreased more in the orlistat group than in the placebo group.
The Lancet  •  1998  |  View Paper
Total cholesterol, low-density lipoprotein (LDL) cholesterol, LDL/high-density lipoprotein ratio, and concentrations of glucose and insulin decreased more in the orlistat group than in the placebo group.
Lancet  •  1998  |  View Paper
Fasting, 14‐hour area under the curve (AUC) and meal‐related AUC for glucose and insulin were similar, although postprandial increases in peak insulin and glucose were greater with orlistat.
Diabetes, obesity & metabolism  •  2020  |  View Paper
…,orlistat produced a reduction of 2.39 kg (95%CI-3.34 to −1.45) for weight, a reduction of 0.… to −0.12) for LDL, a reduction of 0.12 mmol/L (95%CI: −0.20 to −0.04) for fasting glucose , 1.85 mmHg ….58) for DBP.
PloS one  •  2012  |  View Paper
Moreover, orlistat dose-dependently inhibits glucose- and forskolin-stimulated insulin secretion, while leaving glucose oxidation and the rise in the ATP/ADP ratio intact.
Biochemical Society transactions  •  2008  |  View Paper